ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
NCT04051502
Adnexal Diseases, Adnexal Mass
Basking Ridge, New Jersey, United States
View Trial DetailsNCT Number: NCT01466049
The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.
Looking for future studies?
Notify Me18 year and older
Female
Observational
New Hanover Regional Medical Center, Wilmington, North Carolina, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: observational studies
Fujirebio Diagnostics, Inc.
Industry
Evaluation of New Biomarker Assays in Ovarian Cancer Patients Presenting to a Generalist With an Adnexal Mass
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04051502
Adnexal Diseases, Adnexal Mass
Basking Ridge, New Jersey, United States
View Trial DetailsNCT03837327
Adnexal Diseases, Adnexal Mass
Los Angeles, California, United States
View Trial DetailsNCT06366997
Adnexal Diseases, Adnexal Mass
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT03593681
Abdominal Neoplasms, Adnexal Diseases
San Diego, California, United States
View Trial Details